Literature DB >> 22677239

Lymph node dissection in patients with malignant melanoma is associated with high risk of morbidity.

Jamshaid Ul-Mulk1, Lisbet Rosenkrantz Hölmich.   

Abstract

INTRODUCTION: Malignant melanoma is one of the most rapidly increasing cancer types globally, and it is by far the most serious skin cancer. Patients with a melanoma ≥ 1 mm in Breslow thickness are offered sentinel node (SN) biopsy and subsequent radical lymph node dissection if the biopsy is positive. The objective in the present paper was to describe post-operative complications in this group of patients. A standard operation and drainage regime was used.
MATERIAL AND METHODS: This was a retrospective study based on 96 consecutive SN-positive patients with primary cutaneous malignant melanoma who underwent subsequent radical axillary or inguinal lymph node dissection. Fisher's exact test and Mann-Whitney U-test were used to evaluate associations.
RESULTS: In all, 57 patients were male and 39 female. A total of 71 had an axillary and 25 an inguinal operation. The median drainage period was seven days (2-15 days). Forty patients developed seroma which needed puncture; three of these cases were chronic, there was no difference between the two groups. Seroma puncture was only associated with infection in the inguinal group (p = 0.04). 25% in the axillary group were diagnosed with lymph oedema after three months versus 48% in the inguinal group (p = 0.04). A body mass index ≥ 25 kg/m2 was associated with a slight, but non-significant increase in complications (p = 0.08). No association was found for smoking or co-morbidity.
CONCLUSION: Patients undergoing axillary or inguinal lymph node dissection experience a significant number of complications, especially seroma and lymph oedema. Long-term complications are severe and can profoundly impact the patient's quality of life.

Entities:  

Mesh:

Year:  2012        PMID: 22677239

Source DB:  PubMed          Journal:  Dan Med J        ISSN: 2245-1919            Impact factor:   1.240


  9 in total

1.  Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin?

Authors:  Andrei Rios-Cantu; Ying Lu; Victor Melendez-Elizondo; Michael Chen; Alejandra Gutierrez-Range; Niloofar Fadaki; Suresh Thummala; Carla West-Coffee; James Cleaver; Mohammed Kashani-Sabet; Stanley P L Leong
Journal:  Clin Exp Metastasis       Date:  2017-07-11       Impact factor: 5.150

2.  Dissections of regional lymph nodes for treatment of skin cancer: predicting annual caseloads that will optimise outcomes.

Authors:  J K Dickson; A Davies; S Rahman; C Sethu; J R O Smith; A Orlando; D Ayers
Journal:  Ann R Coll Surg Engl       Date:  2015-01       Impact factor: 1.891

3.  National Practice Patterns in the Management of the Regional Lymph Node Basin After Positive Sentinel Lymph Node Biopsy for Cutaneous Melanoma.

Authors:  Cimarron E Sharon; Richard J Straker; Eric H Li; Giorgos C Karakousis; John T Miura
Journal:  Ann Surg Oncol       Date:  2022-08-25       Impact factor: 4.339

4.  VEGF-C improves regeneration and lymphatic reconnection of transplanted autologous lymph node fragments: An animal model for secondary lymphedema treatment.

Authors:  Lia Schindewolffs; Gerhard Breves; Manuela Buettner; Catarina Hadamitzky; Reinhard Pabst
Journal:  Immun Inflamm Dis       Date:  2014-11-17

5.  Saphenous vein sparing superficial inguinal dissection in lower extremity melanoma.

Authors:  Muhammed Beşir Oztürk; Arzu Akan; Ozay Ozkaya; Onur Egemen; Ali Rıza Oreroğlu; Turgut Kayadibi; Mithat Akan
Journal:  J Skin Cancer       Date:  2014-07-13

6.  Prevention of seroma following inguinal lymph node dissection with prophylactic, incisional, negative-pressure wound therapy (SEROMA trial): study protocol for a randomized controlled trial.

Authors:  Mads Gustaf Jørgensen; Navid Mohamadpour Toyserkani; Nana Hyldig; Annette Hougaard Chakera; Lisbet Rosenkrantz Hölmich; Jørn Bo Thomsen; Jens Ahm Sørensen
Journal:  Trials       Date:  2018-08-15       Impact factor: 2.279

7.  Recent Evolution in the Management of Lymph Node Metastases in Melanoma.

Authors:  Shelby Breit; Elise Foley; Elizabeth Ablah; Hayrettin Okut; Joshua Mammen
Journal:  Kans J Med       Date:  2021-03-19

8.  Reducing morbidity with surgical adhesives following inguinal lymph node dissections for the treatment of malignant skin tumors.

Authors:  Peter L Stollwerck; Dominik Schlarb; Nicole Münstermann; Sebastian Stenske; Christoph Kruess; Gerhard Brodner; Björn Dirk Krapohl; Albrecht F Krause-Bergmann
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2016-01-20

9.  The prognostic significance of non-sentinel lymph node metastasis in cutaneous and acral melanoma patients-A multicenter retrospective study.

Authors:  Wei Sun; Yu Xu; JiLong Yang; ZhiChao Liao; Tao Li; Kai Huang; Poulam Patel; WangJun Yan; Yong Chen
Journal:  Cancer Commun (Lond)       Date:  2020-10-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.